Àü¸³¼±¾Ï¼¼Æ÷ÁÖÀÇ ¼ºÀå¿¡ ¹ÌÄ¡´Â Synthetic Tyrosine Kinase Inhibitor(zM260603)ÀÇ ¿µÇâ: ¾Èµå·ÎÁ¨ ÀÇÁ¸¼º°ú Bcl-2 Ç¥Çö¿¡ µû¸¥ Â÷ÀÌ
Effect of Synthetic Tyrosine Kinase Inhibitor(ZM260603) on the Growth of Prostate Cancer Cell Lines: Differences According to Androgen Dependency and Bcl-2 Expression
¾Èµ¿È¯, Á¤ÇöÁ÷, À̵¿Çö, Á¶Àº¼Û,
¼Ò¼Ó »ó¼¼Á¤º¸
¾Èµ¿È¯ ( )
¿¬¼¼´ëÇб³ ÀÇ°ú´ëÇÐ ºñ´¢±â°úÇб³½Ç
Á¤ÇöÁ÷ ( )
¿¬¼¼´ëÇб³ ÀÇ°ú´ëÇÐ ºñ´¢±â°úÇб³½Ç
À̵¿Çö ( )
¿¬¼¼´ëÇб³ ÀÇ°ú´ëÇÐ ºñ´¢±â°úÇб³½Ç
Á¶Àº¼Û ( )
¿¬¼¼´ëÇб³ ÀÇ°ú´ëÇÐ ºñ´¢±â°úÇб³½Ç
KMID : 0358319990400111487
Abstract
[ÃʷϾøÀ½:No abstract]
Å°¿öµå
Tyrosine kinase inhibitor; Prostate cancer cell line; Bcl-2 expression; Androgen-dependency;
¿ø¹® ¹× ¸µÅ©¾Æ¿ô Á¤º¸
µîÀçÀú³Î Á¤º¸